Quest plans to refine, develop and validate the technology and is aiming to launch the test in North America next year.

The recall comes more than one year after Medtronic announced it would exit the ventilator market.

Caris, which offers tools for disease diagnosis, therapy selection and treatment monitoring, is the latest company to test ...

Kate Benedict joined Medtronic as president of the company’s acute care and monitoring business, the company announced Monday ...

The company has asked users to monitor patients frequently to ensure the appropriate infusion is being delivered.

The move comes after a recent investigation found Chinese government procurement practices discriminate against EU companies ...

Gaeta’s last role was a brief stint at Shockwave, which named her CFO two months before accepting J&J’s $13.1 billion ...

Nvidia, which is already working with J&J and Medtronic, plans to partner with medtech companies to build platforms for ...

The startup received de novo authorization for the AI tool, the first of its kind that analyzes mammogram images to predict ...

Tandem will integrate its insulin delivery systems with a new dual glucose-ketone sensor being developed by Abbott.

Joseph Wolk told an investor conference that the company’s tariff estimate is a “moving target” as trade talks continue with ...

The Trump Administration has effectively ended the Biden Administration's attempt to regulate lab-developed tests,” TD Cowen ...